Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
出版年份 2018 全文链接
标题
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA
Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
作者
关键词
-
出版物
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 103, Issue 4, Pages 574-581
出版商
Wiley
发表日期
2018-02-02
DOI
10.1002/cpt.1004
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis
- (2017) Damayanti Das Ghosh et al. INTERNATIONAL JOURNAL OF CANCER
- HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis
- (2017) Kanoot Jaruthamsophon et al. Scientific Reports
- Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
- (2016) Chun-Bing Chen et al. NEUROLOGY
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
- (2015) Y Saito et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 Update
- (2014) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing
- (2014) K E Caudle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Impaired Nef Function Is Associated with Early Control of HIV-1 Viremia
- (2014) X. T. Kuang et al. JOURNAL OF VIROLOGY
- Effects of a HLA-B*15:02 screening policy on antiepileptic drug use and severe skin reactions
- (2014) Z. Chen et al. NEUROLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
- (2013) S G Leckband et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
- (2012) V L Yip et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
- (2012) M A Martin et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans
- (2011) Sae-Hoon Kim et al. EPILEPSY RESEARCH
- Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
- (2011) Choong-Chor Chang et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Drug hypersensitivity: Pharmacogenetics and clinical syndromes
- (2011) Elizabeth J. Phillips et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- PharmGKB summary
- (2011) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
- (2010) Nahoko Kaniwa et al. EPILEPSIA
- Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
- (2010) Wichittra Tassaneeyakul et al. EPILEPSIA
- Association of HLA-BFNx011502 allele and carbamazepine-inducedStevens-Johnson syndromeamong Indians
- (2009) TimirY Mehta et al. Indian Journal of Dermatology Venereology & Leprology
- Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
- (2008) Chaichon Locharernkul et al. EPILEPSIA
- A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
- (2008) Christine Lonjou et al. Pharmacogenetics and Genomics
- HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis
- (2008) Nahoko Kaniwa et al. PHARMACOGENOMICS
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started